Try our Advanced Search for more refined results

Teva Fights To Invalidate Astellas' Urinary Drug Patent

By Lucia Osborne-Crowley ( June 8, 2021, 1:09 PM BST) -- Teva has urged a London court to invalidate a U.K. patent held by Astellas for a urinary incontinence drug because it allegedly involves an obvious scientific formula, as the generic drug giant hit back at the Japanese pharmaceutical company's infringement lawsuit....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!